Clinical trial
Gene Therapy in Treating Patients With Cancer of The Liver
NCT00003147 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00003147 |
|---|---|
| Title | Gene Therapy in Treating Patients With Cancer of The Liver |
| Official title | Phase I Study of Percutaneous Injections of Adeno-Virus p53 Construct (ADENO-p53) for Hepatocellular Carcinoma |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Biological |
| Interventions | Ad5CMV-p53 gene |
| Enrollment | 30 |
| Start date | Feb 1, 1998 |
| Primary completion | Jun 1, 2003 |
| First posted | Aug 24, 2004 |
| Last update posted | Feb 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: